【百家大讲堂】第279期：视频率高光谱成像使光谱超视觉成为可能:临床诊断与外科中的一项颠覆性技术
讲座题目：视频率高光谱成像使光谱超视觉成为可能:临床诊断与外科中的一项颠覆性技术
Video-Rate Hyperspectral Imaging Enables Spectral Hyper Vision: A Game-Changing Technology in Clinical Diagnosis and Surgery
报 告 人：Costas Balas
时 间：2019年11月21日(周四)10:00-12:00
地 点：中关村校区研究生教学楼101报告厅
主办单位：研究生院、信息与电子学院
报名方式：登录华体会hth·(体育)(中国)官方网站-华体会体育hth首页微信企业号---第二课堂---课程报名中选择“【百家大讲堂】第279期：视频率高光谱成像使光谱超视觉成为可能:临床诊断与外科中的一项颠覆性技术”
【主讲人简介】
Costas Balas在希腊佩特雷大学获得医学物理和生物医学工程的物理学位和博士学位。他是希腊查尼亚克里特岛技术大学电子与计算机工程学院(ECE)的教授，是ECE学院电子实验室主任和实验室光子学集团的创始人和领导。他的研究兴趣包括生物光子学和高光谱成像。Balas教授曾在9家期刊担任主编/编委，在国际会议上做过50多次邀请/全体会议演讲，发表过100多篇文章和书籍章节，并拥有多项专利。
Costas Balas received the Physics Degree and the PhD in Medical Physics and Biomedical Engineering, both from the University of Patras Greece. He is a Professor in the School of Electrical and Computer Engineering (ECE) at the Technical University of Crete, Chania, Greece. He is the Director of the ECE School Electronics Lab and the founder and leader of Lab’s photonics group. His research interests span both biophotonics and hyperspectral imaging. Costas Balas has served as Gest Editor/Editorial Board Member in 9 journals, given more than 50 invited/plenary talks in international conferences, and published more than 100 per-reviewed articles and book chapters.
本次报告将着重介绍理想高光谱成像系统的新发展。报告将首先介绍一种结合了几乎实时的光谱分类算法以及以视频速率显示的整个系统输出光谱图的先进的、小型化的硬件配置。这是一种新兴的技术，光谱超视觉，有望从根本上提高诊断和手术治疗的准确性。报告还将介绍新一代的皮肤镜、内窥镜和妇科显微镜，并展示国际临床试验的结果，证实其优于传统方法。
This talk will emphasize on new developments towards an ideal hyperspectral imaging system. The talk will firstly present an advanced, miniaturized hardware configuration, combined with nearly real time spectral classification algorithms, with the total system outputting spectral maps displayed at video rates. This is synonymous to spectral hyper vision , an emerging technology holding the promise to radically improve the diagnostic and surgical treatment accuracy outcomes in several medical practices. A new generation of skin scopes, endoscopes and gynecologic microscopes, implementing this new technology will be presented, together with results from international clinical trials confirming superior performance over traditional methods.